These final results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the concept of focusing on ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Conditions. This wellness health supplement https://alexandrex061tkd7.wikigop.com/user